BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9918572)

  • 1. Ropivacaine inhibits serum-induced proliferation of colon adenocarcinoma cells in vitro.
    Martinsson T
    J Pharmacol Exp Ther; 1999 Feb; 288(2):660-4. PubMed ID: 9918572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ropivacaine on eicosanoid release from human granulocytes and endothelial cells in vitro.
    Martinsson T; Haegerstrand A; Dalsgaard CJ
    Inflamm Res; 1997 Oct; 46(10):398-403. PubMed ID: 9372311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ropivacaine and lidocaine inhibit proliferation of non-transformed cultured adult human fibroblasts, endothelial cells and keratinocytes.
    Martinsson T; Haegerstrand A; Dalsgaard CJ
    Agents Actions; 1993 Sep; 40(1-2):78-85. PubMed ID: 8147273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ropivacaine on adhesion molecule CD11b expression and function in human neutrophils.
    Zhu X; Tan Z; Chen J; Zhu M; Xu Y
    Int Immunopharmacol; 2010 Jun; 10(6):662-7. PubMed ID: 20348036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ropivacaine inhibits leukocyte rolling, adhesion and CD11b/CD18 expression.
    Martinsson T; Oda T; Fernvik E; Roempke K; Dalsgaard CJ; Svensjö E
    J Pharmacol Exp Ther; 1997 Oct; 283(1):59-65. PubMed ID: 9336308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of topical ropivacaine on eicosanoids and neurotransmitters in the rectum of patients with distal ulcerative colitis.
    Hillingsø JG; Kjeldsen J; Schmidt PT; Rasmussen TN; Fisher-Hansen B; Holst JJ; Lauristen K; Bukhave K; Rask-Madsen J
    Scand J Gastroenterol; 2002 Mar; 37(3):325-9. PubMed ID: 11916195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-aminosalicylic acid in combination with nimesulide inhibits proliferation of colon carcinoma cells in vitro.
    Fang HM; Mei Q; Xu JM; Ma WJ
    World J Gastroenterol; 2007 May; 13(20):2872-7. PubMed ID: 17569127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ropivacaine, bupivacaine and sufentanil in colon and pancreatic cancer cells in vitro.
    Bundscherer A; Malsy M; Gebhardt K; Metterlein T; Plank C; Wiese CH; Gruber M; Graf BM
    Pharmacol Res; 2015; 95-96():126-31. PubMed ID: 25839130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
    Williams JL; Borgo S; Hasan I; Castillo E; Traganos F; Rigas B
    Cancer Res; 2001 Apr; 61(8):3285-9. PubMed ID: 11309281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct effect of ropivacaine involves lipoxygenase pathway activation in rat aortic smooth muscle.
    Sung HJ; Sohn JT; Park JY; Hwang EM; Baik JS; Ogawa K
    Can J Anaesth; 2009 Apr; 56(4):298-306. PubMed ID: 19296191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of prostaglandin E2 by curcumin is correlated with inhibition of cell growth and induction of apoptosis in human colon carcinoma cell lines.
    Lev-Ari S; Maimon Y; Strier L; Kazanov D; Arber N
    J Soc Integr Oncol; 2006; 4(1):21-6. PubMed ID: 16737669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells.
    Kuo SM
    Cancer Lett; 1996 Dec; 110(1-2):41-8. PubMed ID: 9018079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of ropivacaine in rat experimental colitis.
    Martinsson T; Ljung T; Rubio C; Hellström PM
    J Pharmacol Exp Ther; 1999 Nov; 291(2):642-7. PubMed ID: 10525083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fuscoside: an anti-inflammatory marine natural product which selectively inhibits 5-lipoxygenase. Part II: Biochemical studies in the human neutrophil.
    Jacobson PB; Jacobs RS
    J Pharmacol Exp Ther; 1992 Aug; 262(2):874-82. PubMed ID: 1323665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis.
    Casellas F; Papo M; Guarner F; Antolín M; Segura RM; Armengol JR; Malagelada JR
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):221-6. PubMed ID: 7743303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of local anesthetic ropivacaine on isolated rat liver mitochondria.
    Floridi A; Di Padova M; Barbieri R; Arcuri E
    Biochem Pharmacol; 1999 Sep; 58(6):1009-16. PubMed ID: 10509753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of local anesthetics on human bladder contractility.
    Oh SJ; Paick SH; Lim DJ; Lee E; Lee SE
    Neurourol Urodyn; 2005; 24(3):288-94. PubMed ID: 15714441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lidocaine has better antioxidant potential than ropivacaine and bupivacaine: in vitro comparison in a model of human erythrocytes submitted to an oxidative stress.
    Lenfant F; Lahet JJ; Courderot-Masuyer C; Freysz M; Rochette L
    Biomed Pharmacother; 2004 May; 58(4):248-54. PubMed ID: 15183851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of TNF-alpha and inhibitors of arachidonic acid metabolism on human colon HT-29 cells depend on differentiation status.
    Kovaríková M; Hofmanová J; Soucek K; Kozubík A
    Differentiation; 2004 Feb; 72(1):23-31. PubMed ID: 15008823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of local anesthetic ropivacaine on the energy metabolism of Ehrlich ascites tumor cells.
    Di Padova M; Barbieri R; Fanciulli M; Arcuri E; Floridi A
    Oncol Res; 1998; 10(10):491-8. PubMed ID: 10338152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.